Langsam Jeffrey (CIK 2069752) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-01). Recent activity: Buy TOI (70,270 shares), Buy TOI (57,380 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-01 | Oncology Institute, Inc. (TOI) | Chief Clinical Officer | Buy | 70,270 | $0 |
| 2025-05-23 | Oncology Institute, Inc. (TOI) | Chief Clinical Officer | Buy | 57,380 | $0 |
Source: SEC Form 4 filings · as of 2026-04-01